Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and pulmicort

cetylpyridinium chloride anhydrous has been researched along with pulmicort in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Behrend, EN; Kemppainen, RJ; Smith-Carr, S; Stroup, ST1
Celedón, JC; Cohen, RT; Fuhlbrigge, AL; Raby, BA; Rosner, BA; Strunk, RC; Van Steen, K; Weiss, ST; Zeiger, RS1

Trials

1 trial(s) available for cetylpyridinium chloride anhydrous and pulmicort

ArticleYear
In utero smoke exposure and impaired response to inhaled corticosteroids in children with asthma.
    The Journal of allergy and clinical immunology, 2010, Volume: 126, Issue:3

    Topics: Administration, Inhalation; Adrenal Cortex Hormones; Asthma; Budesonide; Child; Child, Preschool; Female; Functional Residual Capacity; Health; Humans; Longitudinal Studies; Male; Pregnancy; Prenatal Exposure Delayed Effects; Time Factors; Tobacco Smoke Pollution; Treatment Outcome

2010

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and pulmicort

ArticleYear
Effects of oral administration of controlled-ileal-release budesonide and assessment of pituitary-adrenocortical axis suppression in clinically normal dogs.
    American journal of veterinary research, 2006, Volume: 67, Issue:7

    Topics: Administration, Oral; Adrenocorticotropic Hormone; Alkaline Phosphatase; Animals; Anti-Inflammatory Agents; Budesonide; Delayed-Action Preparations; Dogs; Health; Hydrocortisone; Ileum; Male; Pituitary-Adrenal Function Tests; Pituitary-Adrenal System

2006